Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-29 @ 8:02 AM
Study NCT ID:
NCT01337557
Status:
UNKNOWN
Last Update Posted:
2011-04-19
First Post:
2011-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Sponsor:
Hom, Milton M., OD, FAAO
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2011-11
Completion Date Type:
ESTIMATED
First Submit Date:
2011-04-14
First Submit QC Date:
None
Study First Post Date:
2011-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-04-18
Last Update Post Date:
2011-04-19
Last Update Post Date Type:
ESTIMATED